Superbiotics

Superbiotics is a South Korean biotechnology company specializing in the development of microbiome-derived therapeutics, often referred to as "pharmabiotics." As a subsidiary of Bifido Co., Ltd., the company leverages a proprietary platform to identify and characterize human-origin Bifidobacterium and Lactobacillus strains with clinical potential. Their lead program, BGN4, is currently being evaluated in clinical trials for atopic dermatitis and is in pre-clinical development for rheumatoid arthritis. The company also conducts research into the gut-brain axis for neurodegenerative conditions like Alzheimer's disease and develops treatments for viral infections such as rotavirus. Superbiotics maintains integrated capabilities ranging from strain discovery to GMP-compliant microbial manufacturing.